{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T01:23:24Z","timestamp":1574472204701},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:00:00Z","timestamp":1443225600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00125-015-3769-3","type":"article-journal","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T22:10:24Z","timestamp":1443219024000},"page":"30-43","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":"Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis","prefix":"10.1007","volume":"59","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Konstantinos N.","family":"Aronis","sequence":"additional","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Dimitrios D.","family":"Raptis","sequence":"additional","affiliation":[]},{"given":"Maria F.","family":"Vasiloglou","sequence":"additional","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,9,26]]},"reference":[{"key":"3769_CR1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","volume":"72","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kountouras J, Zavos C (2009) Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 72:299\u2013314","journal-title":"Curr Mol Med"},{"key":"3769_CR2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274\u2013285","journal-title":"Aliment Pharmacol Ther"},{"key":"3769_CR3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7326\/0003-4819-152-2-201001190-00008","volume":"152","author":"T Kelesidis","year":"2010","unstructured":"Kelesidis T, Kelesidis I, Chou S, Mantzoros CS (2010) Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med 152:93\u2013100","journal-title":"Ann Intern Med"},{"key":"3769_CR4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1210\/er.2012-1053","volume":"34","author":"HS Moon","year":"2013","unstructured":"Moon HS, Dalamaga M, Kim SY et al (2013) Leptin\u2019s role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev 34:377\u2013412","journal-title":"Endocr Rev"},{"key":"3769_CR5","doi-asserted-by":"crossref","first-page":"E567","DOI":"10.1152\/ajpendo.00315.2011","volume":"301","author":"CS Mantzoros","year":"2011","unstructured":"Mantzoros CS, Magkos F, Brinkoetter M et al (2011) Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 301:E567\u2013E584","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3769_CR6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cmet.2013.05.010","volume":"18","author":"M Dalamaga","year":"2013","unstructured":"Dalamaga M, Chou SH, Shields K, Papageorgiou P, Polyzos SA, Mantzoros CS (2013) Leptin at the intersection of neuroendocrinology and metabolism: current evidence and therapeutic perspectives. Cell Metab 18:29\u201342","journal-title":"Cell Metab"},{"key":"3769_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MCG.0b013e3181ec5c66","volume":"45","author":"SA Polyzos","year":"2011","unstructured":"Polyzos SA, Kountouras J, Zavos C, Deretzi G (2011) The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of literature. J Clin Gastroenterol 45:50\u201354","journal-title":"J Clin Gastroenterol"},{"key":"3769_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","volume":"16","author":"K Imajo","year":"2012","unstructured":"Imajo K, Fujita K, Yoneda M et al (2012) Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling. Cell Metab 16:44\u201354","journal-title":"Cell Metab"},{"key":"3769_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS (2015) Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism 64:60\u201378","journal-title":"Metabolism"},{"key":"3769_CR10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.metabol.2013.10.010","volume":"63","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA, Mantzoros CS (2014) Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease. Metabolism 63:161\u2013167","journal-title":"Metabolism"},{"key":"3769_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.metabol.2014.10.017","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"Polyzos SA, Mantzoros CS (2015) Leptin in health and disease: facts and expectations at its twentieth anniversary. Metabolism 64:5\u201312","journal-title":"Metabolism"},{"key":"3769_CR12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008\u20132012","journal-title":"JAMA"},{"key":"3769_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.metabol.2010.09.003","volume":"60","author":"SA Polyzos","year":"2011","unstructured":"Polyzos SA, Toulis KA, Goulis DG, Zavos C, Kountouras J (2011) Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism 60:313\u2013326","journal-title":"Metabolism"},{"key":"3769_CR14","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR (1999) Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94:2467\u20132474","journal-title":"Am J Gastroenterol"},{"key":"3769_CR15","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van NM et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313\u20131321","journal-title":"Hepatology"},{"key":"3769_CR16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264\u2013269","journal-title":"Ann Intern Med"},{"key":"3769_CR17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jhep.2004.08.020","volume":"41","author":"P Angulo","year":"2004","unstructured":"Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD (2004) Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol 41:943\u2013949","journal-title":"J Hepatol"},{"key":"3769_CR18","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s11695-009-9912-9","volume":"19","author":"M Argentou","year":"2009","unstructured":"Argentou M, Tiniakos DG, Karanikolas M et al (2009) Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery. Obes Surg 19:1313\u20131323","journal-title":"Obes Surg"},{"key":"3769_CR19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1665-2681(19)31856-3","volume":"7","author":"B Canbakan","year":"2008","unstructured":"Canbakan B, Tahan V, Balci H et al (2008) Leptin in nonalcoholic fatty liver disease. Ann Hepatol 7:249\u2013254","journal-title":"Ann Hepatol"},{"key":"3769_CR20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1478-3231.2006.01337.x","volume":"26","author":"A Cayon","year":"2006","unstructured":"Cayon A, Crespo J, Mayorga M, Guerra A, Pons-Romero F (2006) Increased expression of Ob-Rb and its relationship with the overexpression of TGF-\u03b21 and the stage of fibrosis in patients with nonalcoholic steatohepatitis. Liver Int 26:1065\u20131071","journal-title":"Liver Int"},{"key":"3769_CR21","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1111\/j.1572-0241.2003.08767.x","volume":"98","author":"N Chalasani","year":"2003","unstructured":"Chalasani N, Crabb DW, Cummings OW et al (2003) Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis? Am J Gastroenterol 98:2771\u20132776","journal-title":"Am J Gastroenterol"},{"key":"3769_CR22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.22063","volume":"47","author":"M Charlton","year":"2008","unstructured":"Charlton M, Angulo P, Chalasani N et al (2008) Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology 47:484\u2013492","journal-title":"Hepatology"},{"key":"3769_CR23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/jhep.2002.34738","volume":"36","author":"S Chitturi","year":"2002","unstructured":"Chitturi S, Farrell G, Frost L et al (2002) Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? Hepatology 36:403\u2013409","journal-title":"Hepatology"},{"key":"3769_CR24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/MEG.0b013e328345c8c7","volume":"23","author":"S Dasarathy","year":"2011","unstructured":"Dasarathy S, Yang Y, McCullough AJ, Marczewski S, Bennett C, Kalhan SC (2011) Elevated hepatic fatty acid oxidation, high plasma fibroblast growth factor 21, and fasting bile acids in nonalcoholic steatohepatitis. Eur J Gastroenterol Hepatol 23:382\u2013388","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3769_CR25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.2047-6310.2012.00082.x","volume":"7","author":"E Fitzpatrick","year":"2012","unstructured":"Fitzpatrick E, Dew TK, Quaglia A, Sherwood RA, Mitry RR, Dhawan A (2012) Analysis of adipokine concentrations in paediatric non-alcoholic fatty liver disease. Pediatr Obes 7:471\u2013479","journal-title":"Pediatr Obes"},{"key":"3769_CR26","first-page":"2422","volume":"46","author":"E Giannini","year":"1999","unstructured":"Giannini E, Botta F, Cataldi A et al (1999) Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. Hepatogastroenterology 46:2422\u20132425","journal-title":"Hepatogastroenterology"},{"key":"3769_CR27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1600-079X.2012.01023.x","volume":"54","author":"M Gonciarz","year":"2013","unstructured":"Gonciarz M, Bielanski W, Partyka R et al (2013) Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin. J Pineal Res 54:154\u2013161","journal-title":"J Pineal Res"},{"key":"3769_CR28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1530\/EJE-11-0864","volume":"166","author":"JW Haukeland","year":"2012","unstructured":"Haukeland JW, Dahl TB, Yndestad A et al (2012) Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. Eur J Endocrinol 166:503\u2013510","journal-title":"Eur J Endocrinol"},{"key":"3769_CR29","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3748\/wjg.14.2888","volume":"14","author":"XD Huang","year":"2008","unstructured":"Huang XD, Fan Y, Zhang H et al (2008) Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. World J Gastroenterol 14:2888\u20132893","journal-title":"World J Gastroenterol"},{"key":"3769_CR30","first-page":"46","volume":"40","author":"JM Hui","year":"2004","unstructured":"Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J (2004) Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40:46\u201354","journal-title":"Hepatology"},{"key":"3769_CR31","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/oby.2009.89","volume":"17","author":"SR Kashyap","year":"2009","unstructured":"Kashyap SR, Diab DL, Baker AR et al (2009) Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. Obesity (Silver Spring) 17:1696\u20131701","journal-title":"Obesity (Silver Spring)"},{"key":"3769_CR32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1478-3231.2011.02637.x","volume":"32","author":"E Koehler","year":"2012","unstructured":"Koehler E, Swain J, Sanderson S, Krishnan A, Watt K, Charlton M (2012) Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients. Liver Int 32:279\u2013286","journal-title":"Liver Int"},{"key":"3769_CR33","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00464-006-9185-5","volume":"21","author":"D Le","year":"2007","unstructured":"Le D, Marks D, Lyle E et al (2007) Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients. Surg Endosc 21:1593\u20131599","journal-title":"Surg Endosc"},{"key":"3769_CR34","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1478-3231.2009.02022.x","volume":"29","author":"M Lemoine","year":"2009","unstructured":"Lemoine M, Ratziu V, Kim M et al (2009) Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease. Liver Int 29:1431\u20131438","journal-title":"Liver Int"},{"key":"3769_CR35","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1097\/MEG.0b013e32835609b0","volume":"24","author":"MV Machado","year":"2012","unstructured":"Machado MV, Coutinho J, Carepa F, Costa A, Proenca H, Cortez-Pinto H (2012) How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 24:1166\u20131172","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3769_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00592-008-0063-6","volume":"46","author":"M Manco","year":"2009","unstructured":"Manco M, Giordano U, Turchetta A et al (2009) Insulin resistance and exercise capacity in male children and adolescents with non-alcoholic fatty liver disease. Acta Diabetol 46:97\u2013104","journal-title":"Acta Diabetol"},{"key":"3769_CR37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1665-2681(19)31790-9","volume":"8","author":"LE Munoz","year":"2009","unstructured":"Munoz LE, Cordero P, Torres L, Sauceda AY, Flores JP, Segura JJ (2009) Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis. Ann Hepatol 8:123\u2013128","journal-title":"Ann Hepatol"},{"key":"3769_CR38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.20896","volume":"42","author":"G Musso","year":"2005","unstructured":"Musso G, Gambino R, Durazzo M et al (2005) Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 42:1175\u20131183","journal-title":"Hepatology"},{"key":"3769_CR39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/eje.1.02288","volume":"155","author":"V Nobili","year":"2006","unstructured":"Nobili V, Manco M, Ciampalini P et al (2006) Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol 155:735\u2013743","journal-title":"Eur J Endocrinol"},{"key":"3769_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/eje.1.01821","volume":"152","author":"C Pagano","year":"2005","unstructured":"Pagano C, Soardo G, Esposito W et al (2005) Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J Endocrinol 152:113\u2013118","journal-title":"Eur J Endocrinol"},{"key":"3769_CR41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2036.2011.04929.x","volume":"35","author":"S Petta","year":"2012","unstructured":"Petta S, Amato MC, Di Marco V et al (2012) Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 35:238\u2013247","journal-title":"Aliment Pharmacol Ther"},{"key":"3769_CR42","first-page":"772","volume":"107","author":"I Pirvulescu","year":"2012","unstructured":"Pirvulescu I, Gheorghe L, Csiki I et al (2012) Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. Chirurgia (Bucur) 107:772\u2013779","journal-title":"Chirurgia (Bucur)"},{"key":"3769_CR43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.metabol.2013.09.013","volume":"63","author":"SA Polyzos","year":"2014","unstructured":"Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS (2014) Irisin in patients with nonalcoholic fatty liver disease. Metabolism 63:207\u2013217","journal-title":"Metabolism"},{"key":"3769_CR44","first-page":"986","volume":"137","author":"DK Singh","year":"2013","unstructured":"Singh DK, Sakhuja P, Rastogi A, Singh A, Gondal R, Sarin SK (2013) Serum leptin levels correlate with body mass index but not with histologic disease severity in Indian patients with non-alcoholic steatohepatitis: a pilot study. Indian J Med Res 137:986\u2013987","journal-title":"Indian J Med Res"},{"key":"3769_CR45","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/iub.597","volume":"64","author":"M Swellam","year":"2012","unstructured":"Swellam M, Hamdy N (2012) Association of nonalcoholic fatty liver disease with a single nucleotide polymorphism on the gene encoding leptin receptor. IUBMB Life 64:180\u2013186","journal-title":"IUBMB Life"},{"key":"3769_CR46","first-page":"490","volume":"89","author":"R Tungtrongchitr","year":"2006","unstructured":"Tungtrongchitr R, Treeprasertsuk S, Ei NN, Thepouyporn A, Phonrat B, Huntrup A (2006) Serum leptin concentrations in chronic hepatitis. J Med Assoc Thail 89:490\u2013499","journal-title":"J Med Assoc Thail"},{"key":"3769_CR47","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1111\/j.1572-0241.2000.03297.x","volume":"95","author":"A Uygun","year":"2000","unstructured":"Uygun A, Kadayifci A, Yesilova Z et al (2000) Serum leptin levels in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 95:3584\u20133589","journal-title":"Am J Gastroenterol"},{"key":"3769_CR48","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cgh.2006.06.011","volume":"4","author":"VW Wong","year":"2006","unstructured":"Wong VW, Hui AY, Tsang SW et al (2006) Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 4:1154\u20131161","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3769_CR49","doi-asserted-by":"crossref","first-page":"34295","DOI":"10.1155\/MI\/2006\/34295","volume":"2006","author":"M Yalniz","year":"2006","unstructured":"Yalniz M, Bahcecioglu IH, Ataseven H et al (2006) Serum adipokine and ghrelin levels in nonalcoholic steatohepatitis. Mediat Inflamm 2006:34295","journal-title":"Mediat Inflamm"},{"key":"3769_CR50","first-page":"1","volume":"7","author":"M Egger","year":"2003","unstructured":"Egger M, Juni P, Bartlett C, Holenstein F, Sterne J (2003) How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess 7:1\u201376","journal-title":"Health Technol Assess"}],"container-title":"Diabetologia","original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-015-3769-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-015-3769-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-015-3769-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:19:31Z","timestamp":1567210771000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,26]]},"references-count":50,"journal-issue":{"published-print":{"date-parts":[[2016,1]]},"issue":"1"},"alternative-id":["3769"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00125-015-3769-3","relation":{"cites":[]},"ISSN":["0012-186X","1432-0428"],"subject":["Internal Medicine","Endocrinology, Diabetes and Metabolism"],"container-title-short":"Diabetologia"}